- Conditions
- Astrocytoma, Astrocytoma, Grade III, Glioblastoma, +17 more
- Locations
-
- Northwestern Memorial Hospital Chicago, Illinois, United States
- New York University Langone Medical Center New York, United States
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center New York, United States
- Baylor Scott & White Research Institute Dallas, Texas, United States
Clinical trial condition
Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
Explore clinical trials studying Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype. Study availability and eligibility vary by location and protocol.
11 public trials
6 recruiting studies
Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype trial results
Recruiting
Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
NCT07416188
- Conditions
- Astrocytoma, Brain Cancer, Brain Diseases, +32 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT07668869
- Conditions
- Astrocytoma, Glioblastoma, Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype, +10 more
- Locations
-
- Department of Neurooncology and Radiosurgery, Franciszek Lukaszczyk Oncology Center Bydgoszcz, Poland
Recruiting
Feasibility of ONCOhabitats for Surgical and Treatment Planning in IDH-Wildtype Glioblastoma (SINUE)
NCT07111195
- Conditions
- Astrocytoma, Glioblastoma, Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype, +8 more
- Locations
-
- Hospital General Universitario Dr. Balmis Alicante, Spain
- Hopsital Universitari Vall d'Hebron Barcelona, Spain
- Hospital Clínico Universitario Virgen de la Arrixaca Murcia, Spain
- Hospital Universitario de Canarias Santa Cruz de Tenerife, Spain
Recruiting
Study of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed Glioblastoma
NCT06430424
- Conditions
- Astrocytoma, Disease Attributes, Glioblastoma, +13 more
- Locations
-
- CHU de Bordeaux - Hôpital Saint-André, Service d'Oncologie Médicale Bordeaux, France
NCT05879367
- Conditions
- Astrocytoma, Astrocytoma, IDH-Mutant, GBM, +12 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Henry Ford Hospital Detroit, Michigan, United States
- Columbia University Medical Center - Herbert Irving Pavilion New York, United States
- Duke University Durham, North Carolina, United States
Not yet recruiting
Impact of Pesticide Exposure on Survival and Tumor Aggressiveness in Patients With Glioblastoma: A Prospective Clinical Study
NCT07788430
- Conditions
- Astrocytoma, Glioblastoma, Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype, +8 more
- Locations
-
- Institut Universitaire du Cancer de Toulouse - Oncopole Toulouse, France
Not yet recruiting
Laser Interstitial Thermal Therapy (LiTT) With Cemiplimab or Other Chemotherapy in Recurrent Glioblastomas
NCT07620548
- Conditions
- Astrocytoma, Disease Attributes, Glioblastoma, +13 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
- Washington University School of Medicine St Louis, Missouri, United States
Not yet recruiting
The GLIOMAX Study: MT027 Allogeneic CAR-T for Recurrent Glioma
NCT07386002
- Conditions
- Disease Attributes, Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype, Pathologic Processes, +2 more
- Locations
-
- The Johns Hopkins Sidney Kimmel Cancer Center Baltimore, Maryland, United States
- Hualien Tzu Chi Hospital Hualien City, Taiwan
- Chang Gung Memorial Hospital, Kaohsiung Kaohsiung City, Taiwan
- Chang Gung Memorial Hospital, Linkou Taoyuan, Taiwan
Enrolling by invitation
Clinical Study on the Safety and Immunogenicity of Specific Cancer Vaccines in Preventing Recurrence of Glioblastoma
NCT07520214
- Conditions
- Glioblastom WHO Grade 4, Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
- Locations
-
- Beijing Tiantan Hospital Beijing, Beijing Municipality, China